28 July 2022

Safety alerts

Reference: CIR-2022-00000154

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Pharmaceutical products containing metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk Metformin

Urgent Field Safety Notice Venflon™ Pro Safety (VPS) Needle Protected IV Cannula

 

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

 

 

Supporting Documents:

اضافة تحذير على المنتج - Metformin ---.pdf:

View Document

تقارير السلامة للوسائل الطبية - Venflon™ Pro Safety (VPS) Needle Protected IV Cannula 00.docx.pdf:

View Document